NCT05457010
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05457010
Title Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome.
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kite, A Gilead Company
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.